BDC partners with Accel-Rx to seed health sciences companies
BDC Venture Capital and Accel-Rx Health Sciences Accelerator have formed a partnership to provide seed funding to Canadian health sciences startups. Accel-Rx, BDC and CDRD Ventures jointly will focus on company creation and the supply of resources needed for growth and development. The seed capital partnership with BDC will be the main funding mechanism, with selected Accel-Rx companies each receiving a $500,000 convertible note. The initial goal will be investments in up to four companies annually, with that number potentially increasing over time. Since 2012, BDC has provided $11 million in convertible notes funding to 74 information technology startups.
26 June 2014•5 mins read
